The importance of autophagy in the generation of memory CD8 + T cells in vivo is not well defined. We report here that autophagy was dynamically regulated in virus-specific CD8 + T cells during acute infection of mice with lymphocytic choriomeningitis virus. In contrast to the current paradigm, autophagy decreased in activated proliferating effector CD8 + T cells and was then upregulated when the cells stopped dividing just before the contraction phase. Consistent with those findings, deletion of the gene encoding either of the autophagy-related molecules Atg5 or Atg7 had little to no effect on the proliferation and function of effector cells, but these autophagy-deficient effector cells had survival defects that resulted in compromised formation of memory T cells. Our studies define when autophagy is needed during effector and memory differentiation and warrant reexamination of the relationship between T cell activation and autophagy.
CD8 + T cells provide protection against intracellular bacterial, parasitic and viral infections, as well as cancers 1, 2 . Following stimulation with antigens, naive CD8 + T cells go through many rounds of proliferation, giving rise to effector T cells, which eliminate infected cells. Upon clearance of the antigens, most effector CD8 + T cells undergo apoptosis, leaving only a small pool of cells to survive and differentiate into memory cells [3] [4] [5] . During this naive-to-effector to memorydifferentiation process, T cells undergo cellular and metabolic reprogramming to shift from anabolic processes and proliferation to catabolic processes and contraction of cell populations to generate memory. It is important to define the role of macroautophagy (called 'autophagy' here) during this process.
Autophagy is an evolutionarily conserved process that involves the engulfment and delivery of cytosolic contents to the lysosome for degradation [6] [7] [8] [9] [10] . This catabolic activity of autophagy is essential for cellular homeostasis and has been suggested to be inversely correlated with cell growth and proliferation 11 . In contrast to that paradigm, it has been reported that autophagy is upregulated in proliferating T cells 9, 12, 13 . Stimulation via the T cell antigen receptor (TCR) promotes the activation and proliferation of T cells and also induces signaling via the metabolic checkpoint kinase mTOR, which would be expected to inhibit rather than induce autophagy 8 . Thus, questions remain about why and how proliferating T cells upregulate autophagy in the presence of positive mTOR signaling when cells need more proteins and organelles to donate to daughter cells. Furthermore, because autophagy has been studied mainly in vitro during the activation of T cells after stimulation via the TCR, little is known about in vivo autophagy activity in antigen-specific T cells during the course of the differentiation of effector and memory T cells after viral infection.
The in vivo function of autophagy in antigen-specific T cells during viral infection remains unclear but is important, as pharmacological manipulation of autophagy is being considered as a treatment for many human diseases 14 . Mice with a conditional null mutation resulting in selective deletion of the gene encoding either of the autophagyrelated molecules Atg5 or Atg7 during early T cell development (through the use of Cre recombinase expressed from T cell-specific gene Lck) have fewer mature peripheral T cells than their wild-type counterparts have 10, 15 . Similarly, chimeric mice reconstituted with Atg5 −/− fetal liver cells have fewer peripheral T cells than do chimeric mice reconstituted with wild-type fetal liver cells 9 . That study also showed that Atg5-deficient T cells exhibit diminished proliferative capacity following in vitro stimulation via the TCR 9 . Although such data indicate that autophagy has a key role in the development and homeostasis of T cells, they shed less light on the function of autophagy molecules in T cells responding to antigen because the cells studied had developed in the absence of autophagy molecules such as Atg5 or Atg7 and exhibited abnormalities in gene expression and mitochondrial number and function 10, 15 . Thus, a new approach using phenotypically normal naive T cells is needed to study the function of autophagy during T cell activation in vivo.
Here we investigated two issues: the kinetics of autophagy activity, and the role of autophagy during the response to lymphocytic choriomeningitis virus (LCMV). In contrast to published observations, we found that autophagy was inversely correlated to T cell proliferation and was substantially inhibited during the early effector stage (that is, when the cells were highly proliferative). Autophagy activity was then upregulated at the peak of expansion (that is, when antigen was cleared and antigen-specific T cells were about to undergo the contraction phase). We also established the importance of autophagyrelated proteins for the development of CD8 + T cell memory in vivo by null mutation of the gene encoding either of two molecules essential for autophagy, Atg5 or Atg7, through the use of the granzyme B-Cre system, in which normal naive T cells developed and the genes encoding autophagy-related molecules were deleted only after T cells were activated with antigen. Our study provides insight into the kinetics and the function of autophagy in antigen-specific CD8 + T cells during effector and memory differentiation.
RESULTS

Dynamic regulation of autophagy in virus-specific T cells
During an acute viral infection, naive CD8 + T cells underwent vigorous clonal expansion, followed by contraction, in which a small percentage of effector cells survived to establish memory ( Fig. 1a ). To study autophagy in antigen-specific CD8 + T cells through the distinct phases of the T cell response, we took several different approaches to analyze the autophagy pathway and autophagic flux in antigen-specific CD8 + T cells after acute infection with the Armstrong strain of LCMV. We isolated P14 CD8 + T cells, which have transgenic expression of a TCR specific for the LCMV glycoprotein peptide epitope of amino acids 33-41 (gp33) , at distinct stages of the T cell response: the expansion phase (cells with a blasting phenotype; day 5 after infection, when virus-specific effector CD8 + T cells are actively proliferating); the peak of expansion (day 8 after infection, when effector CD8 + T cells stop proliferating and decrease in size); the contraction phase (day 15 after infection); and the memory phase (day 30 after infection) ( Fig. 1a,b) . To assess autophagy activity, we first measured the abundance of the microtubule-associated proteins LC3b-I and LC3b-II in the sorted P14 cells. LC3b-II, the lipidated form of LC3b-I, is a classic marker of autophagosomes and is incorporated into the elongating membrane that eventually forms the autophagosome and is subsequently degraded after delivery to the lysosome 7 (Supplementary Fig. 1a ). The quantity of both LC3b-I and LC3b-II in antigen-specific CD8 + T cells peaked at day 5 after infection (Fig. 1c) . The accumulation of LC3b proteins in P14 cells without an increase in LC3b-encoding transcripts at day 5 after infection ( Supplementary Fig. 1b ) would be consistent with either induction of autophagy and increased production of these proteins or inhibition of lysosomal degradation of these proteins. To further assess autophagy activity, we therefore examined expression of the ubiquitin-binding scaffold protein p62 (sequestosome-1). p62 is a widely used marker for measuring autophagic activity, as it is both a substrate of autophagy and an adaptor in targeting ubiquitinated proteins for lysosomal degradation via the autophagy pathway 16 (Supplementary Fig. 1a ). Similar to LC3b, p62 showed its greatest accumulation at day 5 after infection, which was not associated with an increase in the corresponding mRNA encoding p62 ( Fig. 1c and Supplementary Fig. 1c ). We also investigated whether LC3b and p62 proteins accumulated at a much earlier stage of T cell activation. In these experiments, we injected the LCMV gp33 peptide noted above into P14 mice to activate all P14 cells in a short, synchronized time frame. Similar to the results obtained for the activated P14 cells collected from day 5 after infection, we detected more LC3b and p62 proteins at 20 h after activation without an increase in their mRNA ( Supplementary Fig. 1d,e ). These data suggested an altered flux in the autophagy pathway at the early effector stage of the T cell response and were most consistent with a reduction in autophagy during antigen-driven activation of T cells in vivo.
To further define how the highly dynamic autophagy pathway is regulated in vivo during the CD8 + T cell response, we generated a reporter system for autophagy activity by fusing a recombinant mouse LC3b protein to green fluorescent protein (GFP) 7 ( Fig. 2a) . We introduced this fusion protein into P14 cells with a retroviral vector system (consisting of mouse stem cell virus (MSCV) with expression of the transduction marker Thy-1.1 under control of an internal ribosomal entry site (MIT)), by which P14 cells transduced with MIT could be distinguished by the expression of Thy-1.1 ( Fig. 2a and Supplementary Fig. 2a ). This reporter system allowed us to quantify autophagy activity at varying times following LCMV infection by measuring GFP expression by flow cytometry; high autophagy activity was reflected by a reduction in GFP intensity due to either the enhanced degradation of GFP-LC3b protein through the autophagy pathway or fluorescence quenching of GFP by low pH after fusion of autophagosomes with lysosomes 17 . As a control we used a GFP-tagged mutant of LC3b with substitution of alanine for the glycine at position 120 (G120A), which results in removal of the carboxy-terminal amino acid to which phosphatidylethanolamine is conjugated during the generation of LC3b-II from LC3b-I ( Fig. 2a) ; this results in a failure of this molecule to be incorporated into autophagosomes. Consistent with our immunoblot analysis of LC3b and p62, at day 5 after infection, the GFP intensity of wild-type and mutant LC3b was similar ( Fig. 2b) , indicative of lower autophagic flux. We also observed similar amounts of GFP intensity for wild-type and mutant LC3b at much earlier times after infection (days 2 and 3; Supplementary Fig. 2b-e ). However, at day 8 after infection, there was a difference between wildtype LC3b and mutant LC3b, and we saw a greater frequency of GFP − P14 cells transduced with retrovirus encoding wild-type LC3b than of those transduced with retrovirus encoding the G120A mutant ( Fig. 2b,c) , which suggested substantially greater flux through the autophagy pathway at day 8 than at day 5. This difference between wild-type LC3b and mutant LC3b in their GFP intensity remained through day 30 after infection ( Fig. 2b,c) . In addition to results obtained with this P14 system, we saw a similar change in autophagy flux in endogenous CD8 + T cells specific for the LCMV gp33 epitope (Supplementary Fig. 3 ). To apply the reporter system to endogenous cells, we transduced hematopoietic stem cells with MIT containing sequence encoding GFP-tagged wild-type LC3b or G120A mutant LC3b, followed by adoptive transfer of the transduced cells into lethally irradiated mice ( Supplementary Fig. 3a) . After reconstitution, we infected mice with the Armstrong strain of LCMV and monitored GFP expression in MIT-transduced CD8 + T cells positive for a tetramer of H-2D b and the LCMV gp33 epitope (H-2D b -gp33) ( Supplementary Fig. 3a ). Similar to the results obtained for P14 T cells, GFP expression in H-2D b -gp33 + cells transduced with MIT carrying sequence encoding wild-type LC3b was similar to that in cells transduced with MIT carrying sequence encoding the G120A mutant at day 6 after infection, and we observed a substantial decrease in the expression of GFP-tagged wild-type LC3b at days 8, 15 and 30 after infection ( Supplementary Fig. 3b ). These data indicated that autophagy was diminished in antigen-specific CD8 + T cells during the clonal expansion phase but was substantially increased following the expansion phase and into the memory phase.
As an additional assessment of autophagy, we visualized GFP-LC3b puncta by multispectral imaging flow cytometry (ImageStream) to quantify autophagosomes; GFP puncta reflected the incorporation of lipidated GFP-LC3b onto the elongating phagophore membrane that subsequently formed the autophagosomes. On days 3, 5 and 8 after infection, we observed puncta in P14 cells transduced to express GFP-taggd wild-type LC3b, although we detected a slightly higher frequency of puncta on day 3 after infection ( Fig. 2d,e ). These data indicated that antigen-specific CD8 + T cells were able to form autophagosomes during the expansion phase of the T cell response. Our results suggested that the low autophagy activity during clonal expansion was due to diminished flux through the lysosomal degradation pathway and that, on conclusion of the clonal expansion phase (day 8 after infection), autophagic flux was much greater.
Our results for the in vivo kinetics of autophagy activity in virusspecific CD8 + T cells were unexpected, because published in vitro studies have shown that T cells increase autophagy after TCR stimulation 9, 12, 13 . To further confirm our findings and determine if autophagolysosome formation is indeed inhibited during the clonal expansion phase, we made retroviral vectors expressing a fusion of the red fluorescent protein mCherry and GFP-LC3b ( Fig. 3a) . mCherry has more stable fluorescence than that of GFP under acidic conditions, such as following the fusion of autophagosomes to lysosomes 7, 18, 19 ; this allowed us to assess whether LC3b had been delivered from autophagosomes into acidic autophagolysosomes. With this system, enhanced autophagic flux results in less GFP fluorescence than mCherry fluorescence due to the delivery of LC3b into an acidic environment 7, 18, 19 . We assessed the formation of autophagolysosomes in antigen-specific CD8 + T cells during the T cell clonal-expansion phase (day 5) and at the peak of T cell responses (day 8; Fig. 3b ). Consistent with our results reported above, proliferating effector CD8 + T cells at day 5 after infection were larger than effector CD8 + T cells at day 8 after infection, when these cells had stopped proliferating (Fig. 3c) . The ratio of fluorescence intensity of GFP to that of mCherry in P14 cells transduced with retrovirus expressing wild-type LC3b was very similar to that in P14 cells transduced with retrovirus expressing G120A mutant LC3b at day 5 after infection ( Fig. 3d,e ), which indicated that autophagy decreased in proliferating virus-specific CD8 + T cells. In contrast, at day 8 after infection, GFP fluorescence was lower than mCherry fluorescence specifically in the cells transduced to express wild-type LC3b (Fig. 3d ) and the ratio of fluorescence intensity (GFP/mCherry) was 4.3-fold lower in cells transduced to express wild-type LC3b than in cells transduced to express G120A LC3b (Fig. 3e) . These results were consistent with increased delivery of LC3b into autophagolysosomes due to induction of autophagy between day 5 and day 8 after infection. Thus, autophagic flux was inhibited during the T cell clonal expansion phase through the impairment of autophagosome maturation into autophagolysosomes, followed by a rapid induction of autophagy concurrent with the peak of CD8 + T cell effector responses at day 8 after infection.
Atg7 and Atg5 are critical for CD8 + T cell memory generation
To determine the importance of the increase in autophagy activity during the transition phase from effector CD8 + T cells to memory CD8 + T cells, we generated mice with a conditional null mutation by crossing mice with loxP-flanked Atg7 alleles (Atg7 fl/fl ) or Atg5 alleles (Atg5 fl/fl ) with mice carrying a transgene encoding Cre driven by the promoter of the gene encoding granzyme B (Gzmb-Cre) [20] [21] [22] to generate Atg7 fl/fl Gzmb-Cre or Atg5 fl/fl Gzmb-Cre mice. In this system, deletion of Atg7 fl/fl or Atg5 fl/fl occurs specifically upon the expression of Gzmb in activated CD8 + T cells. We infected Atg7 fl/fl Gzmb-Cre mice with LCMV Armstrong strain. To establish the efficacy of the Gzmb-Cre system in the context of Atg7 fl/fl Gzmb-Cre mice, we isolated H-2D b -gp33 + CD8 T cells 8 d after infection (Supplementary Fig. 4a ). Assessment of gene deletion by quantitative PCR showed a reduction of more than 20-fold in genomic copies of the Atg7 fl allele in H-2D b -gp33-specific CD8 + T cells, indicative of 95% deletion of the Atg7 fl allele (Fig. 4a) . We noted similar deletion of Atg7 fl in the bulk-activated (CD44 hi CD62L lo ) CD8 + T cell population, >95% of which were LCMV specific and expressed granzyme B at day 8 after infection 23 (Fig. 4a and Supplementary  Fig. 4b ). The extent of Atg7 fl deletion was also reflected by the abundance of Atg7 protein in bulk-activated CD8 + T cells, whereby Atg7 protein was barely discernible in the CD44 hi CD62L lo effector CD8 + T cell population from Atg7 fl/fl Gzmb-Cre mice (Fig. 4b) . We also confirmed the absence of Atg7 protein by assessing its catalytic activity. Atg7 catalyzes reactions that result in Atg5-Atg12 conjugation and lipidation of LC3-I to give rise to LC3b-II (ref. 6) . The enzymatic activity of Atg7 in the effector CD8 + T cells was significantly diminished, as indicated by the absence of both Atg5-Atg12 conjugation and lipidated LC3-II ( Fig. 4b) . Instead, we detected an abundance of Atg5 protein as an unconjugated species (Fig. 4b) . Furthermore, p62 accumulated in the absence of Atg7 (Fig. 4b) , indicative of defects in autophagic activity. These data indicated the high efficacy of the Cre-loxP system in deleting the target Atg7 fl allele from LCMV-specific CD8 + T cells and the consequent loss of autophagy at a time point (day 8) at which autophagy would normally be increased. In addition, these data confirmed the results of the assays of LC3b and p62 used to measure autophagic flux in primary T cells in vivo.
To assess the importance of Atg7 in antigen-specific CD8 + T cells, we infected Atg7 fl/fl Gzmb-Cre mice with LCMV Armstrong strain and monitored the differentiation of LCMV-specific CD8 + T cells over time. At 8 d after infection, H-2D b -gp33 + CD8 + T cell populations had undergone considerable expansion in both Atg7 fl/fl mice (which do not express Cre) and Atg7 fl/fl Gzmb-Cre mice (Fig. 4c) . Also at day 8 after infection, the memory precursor population characterized as KLRG1 lo CD127 hi was present among Atg7-deficient H-2D b -gp33-specific cells in a proportion similar to that among wild-type cells [3] [4] [5] (Fig. 4c) . Other phenotypic markers, including CD44 and CD62L, showed no considerable difference between the two groups (Supplementary Fig. 4c) . Despite a small reduction in the number of antigen-specific CD8 + T cells among peripheral blood mononuclear cells at day 8 after infection (Fig. 4c) , we detected antigen-specific CD8 + T cells in similar quantities in all tissues examined, including spleen, liver and lungs, in the Atg7 fl/fl and Atg7 fl/fl Gzmb-Cre mice (Fig. 4d) . In support of those data, we did not observe any difference between wild-type and Atg7-deficient antigen-specific CD8 + T cells in their proliferation (as measured by incorporation of the thymidine analog BrdU) or in the number of cells undergoing apoptosis at day 5 after infection, when T cells are rapidly proliferating (Supplementary Fig. 4d-h) .
An important function of CD8 + T cells is the ability to produce the antiviral cytokines interferon-γ (IFN-γ) and tumor-necrosis factor (TNF). Ex vivo stimulation of splenocytes at day 8 after infection using peptides indicated little difference in the ability of cells to produce these cytokines or number of cells producing them (Fig. 4e) . Our data demonstrated that virus-specific CD8 + T cells deficient in Atg7 were able to proliferate and differentiate into functional effector T cells that were similar to their wild-type counterparts. This was consistent with our finding that autophagy was actually diminished in proliferating virus-specific CD8 + T cells.
Immediately following the peak of expansion, we observed the sharpest decrease in virus-specific CD8 + T cells in Atg7-deficient cells between day 8 and day 15 after infection ( Fig. 4f-h) . T cells specific for tetramers containing the dominant LCMV epitopes in Atg7 fl/fl Gzmb-Cre mice, including H-2D b -gp33, H-2D b -gp276, H-2D b -NP396 and H-2K b -gp34, were approximately 5-to 10-fold less abundant in the spleens of Atg7 fl/fl Gzmb-Cre mice than in those of Atg7 fl/fl mice (Fig. 4g) . Few antigen-specific T cells survived the contraction phase to transition into the memory phase (day 30 after infection) in lymphoid or nonlymphoid tissues or in the peripheral blood ( Fig. 4h,i) . Overall, these data indicated that Atg7 was important for the survival of effector CD8 + T cells and that a defective autophagy pathway compromised the formation of a functional CD8 + T cell memory pool. These results correlated very closely with the in vivo kinetics of autophagy. Thus, the survival defects of autophagydeficient effector T cells occurred after day 8 after infection, concurrent with enhanced autophagy of virus-specific T cells.
We sought to determine whether the ubiquitin-like conjugation systems necessary for autophagy were required for the formation of T cell memory by evaluating the importance of a second essential 
g Tetramer-specific cells/spleen npg autophagy-related protein, Atg5. Similar to the Atg7 fl/fl Gzmb-Cre phenotype, Atg5 fl/fl Gzmb-Cre mice infected with LCMV Armstrong strain demonstrated an initial expansion phase (day 8 after infection), followed by a substantial loss of antigen-specific CD8 + T cells (Fig. 5a,b) .
We saw this loss in antigen-specific T cells in all tissues examined at the memory phase in the Atg5 fl/fl Gzmb-Cre mice (Fig. 5c,d) . These data indicated a prosurvival role for proteins involved in the autophagy membrane-elongation complex in antigen-specific CD8 + T cells. The conditional null-mutation system is a powerful tool for investigating the function of a protein in a specific cell population. However, one caveat is that the substantial depletion of antigen-specific CD8 + T cells observed in Atg7 fl/fl Gzmb-Cre mice and Atg5 fl/fl Gzmb-Cre mice during the course of LCMV infection ( Figs. 4 and 5) might have an effect on host environmental factors, such as inflammatory cytokines that could compromise the survival and differentiation of T cells. Furthermore, other cell types, such as natural killer cells, also express granzyme B, which introduces an additional level of complexity in comparisons of experimental and control mice. Published work has linked natural killer cells to the modulation of T cell immunity 24, 25 . To address these issues, we generated chimeras by reconstituting wildtype C57BL/6 (CD45.1 + ) recipient mice with a mixture of congenitally marked bone marrow cells from wild-type C57BL/6 (CD45.1 + ) donor mice and Atg7 fl/fl Gzmb-Cre (CD45.2 + ) donor mice ( Supplementary  Fig. 5a) . This system allowed us to compare changes in the number of wild-type and Atg7 fl/fl Gzmb-Cre antigen-specific CD8 + T cells in the same environment (in the same mouse) and excluded the possibility of factors that act on only one population of these cells. As a control, we also generated chimeras by reconstituting wild-type recipient mice with a mixture of bone marrow from Atg7 fl/fl (CD45.2 + ) donor mice and wild-type (CD45.1 + ) donor mice. After reconstitution, we challenged the recipient mice with LCMV Armstrong strain and assessed virus-specific CD8 + T cells over time. At day 8 after infection, there was a substantial expansion of antigen-specific T cell populations from both Atg7 fl/fl donor cells and Atg7 fl/fl Gzmb-Cre donor cells (Fig. 6a,b) . We longitudinally analyzed the responses of CD8 + T cells specific for H-2D b -gp33 or H-2D b -NP396 during the effector and memory stages (Fig. 6a,b and Supplementary Fig. 5c ). Similar to the results obtained for the mice with conditional null mutations, we observed a decrease of more than 90% in Atg7-deficient LCMV-specific CD8 + T cells (CD45.2 + ) from day 8 to day 15 in chimeras reconstituted with Atg7 fl/fl Gzmb-Cre bone marrow plus C57BL/6 bone marrow, compared with a moderate decrease of 50-60% in the corresponding wild-type (CD45.2 + ) population in control chimeras reconstituted with Atg7 fl/fl bone marrow plus C57BL/6 bone marrow (Fig. 6a,b) . At 4 weeks after infection, there were almost no antigen-specific CD8 + T cells of Atg7 fl/fl Gzmb-Cre (CD45.2 + ) origin throughout the peripheral blood (Fig. 6a,b ) and lymphoid and nonlymphoid tissues of chimeras reconstituted with Atg7 fl/fl Gzmb-Cre bone marrow plus C57BL/6 bone marrow (Fig. 6c) . A considerable proportion of naive (CD44 lo ) CD8 + T cells from the Atg7 fl/fl Gzmb-Cre donor persisted in the chimeras (Supplementary Fig. 5b) , which indicated specific loss of antigen-experienced effector CD8 + T cells from Atg7 fl/fl Gzmb-Cre mice throughout the progression of infection. The cells of wildtype (CD45.1 + ) origin made up most of the reconstituted population in the chimeras (Supplementary Fig. 5b) , so the physiological and pathological conditions closely resembled those of the wild-type mice. Hence, in the absence of potential external variables, such as changes introduced in other cell types or any subtle variations in viral clearance, the defects rising from Atg7 deficiency were cell-intrinsic properties that affected survival of the antigen-specific effector CD8 + T cells to the memory phase. Thus, these data confirmed that the autophagy pathway was critical for memory T cell formation.
Distinct metabolic profiles of Atg7 −/− effector T cells
To investigate the potential mechanism underlying the survival defects of the Atg7-deficient CD8 + T cells, we performed metabolomic and transcriptomic analyses of antigen-specific T cells from Atg7-deficient (Atg7 fl/fl Gzmb-Cre) or 'wild-type' (Atg7 fl/fl ) mice at 8 d after infection with LCMV Armstrong strain. We selected this time point as being representative of a transition point in T cell differentiation before substantial loss of Atg7-deficient cells had occurred. In the H-2D b -gp33 + CD8 + T cells isolated from mice at 8 d after infection, the overall gene-expression pattern of the Atg7-deficient CD8 + T cells closely resembled that of the 'wild-type' group; only a small number of genes showed a substantial difference in expression in the two groups in the DNA microarray data, mostly those encoding molecules associated with the cell cycle (data not shown). However, these cells exhibited distinct metabolic profiles, as measured on a A r t i c l e s liquid chromatography-coupled mass-spectrometry metabolomics platform. Among the metabolites that were significantly different in Atg7-sufficent cells versus Atg7-deficient cells ( Supplementary Table 1 ), many were in well-defined metabolic pathways with clear links to cell survival, and some have been linked to T cell differentiation ( Supplementary  Fig. 6 ). For example, among the pathways that were significantly different in the genotypes were the carnitine shuttle and di-unsaturated fatty acid β-oxidation, both of which are part of fatty acid metabolism in the mitochondria (Fig. 7a) . T cell-intrinsic mitochondrial fatty acid oxidation (FAO) has been shown to be a critical metabolic pathway for the stable development of long-lived memory T cells 26, 27 . These data might indicate that autophagy contributes to the production of the lipid substrates for mitochondrial FAO and the fueling of oxidative phosphorylation in these cells 28 . Consistent with a role for autophagy in lipid metabolism in T cells during the transition to the memory phase, our metabolite analysis showed that lipid biosynthetic pathways were dysregulated in the absence of Atg7 (Fig. 7a) . Also of note, the glucosamine 6-phosphate and glycan-biosynthesis pathways were perturbed in Atg7-deficient T cells ( Fig. 7a and Supplementary  Fig. 6 ). The hexosamine pathway provides substrates for the glycosylation of receptors for growth factor cytokines, which leads to receptor stability and the maintenance of survival signals 29 . Given the importance of growth factor cytokines in supporting the development of memory T cells 2 , it is possible that T cells lacking autophagy machinery cannot maintain the proper growth factor signals that support memory T cell development, linking autophagy to glycosylation and the maintenance of cellular metabolism. Figure 6 Antigen-specific CD8 + T cells lacking Atg7 exhibit cell-intrinsic defects in the development into long-term memory cells in chimeras. (a,b) Flow cytometry of CD8 + T cell obtained from chimeras generated (as in Supplementary Fig. 5a ) by reconstitution of wild-type mice with a mixture of bone marrow cells from Atg7 fl/fl mice and wild-type npg
We further confirmed the metabolomics data reported above by assessing the expression of genes encoding the enzymes associated those metabolite activities. By gene-set-enrichment analysis 30 with the genes encoding those enzymes as a gene set, we found that the expression of genes encoding molecules involved in those metabolic activities was clearly associated with the Atg7-deficient genotype (Fig. 7b) . Overall, several metabolic pathways were altered in Atg7-deficient T cells at day 8 after infection, a result that, when integrated with our transcriptomic studies, suggested that autophagy supports metabolic homeostasis in CD8 + T cells during the transition to the memory phase.
Autophagy in CD8 + T cells is essential for viral control
Autophagy was required for the formation of memory CD8 + T cells during an acute viral infection, as shown above. Next we determined whether autophagy regulates CD8 + T cell responses during a chronic viral infection. We challenged Atg7 fl/fl Gzmb-Cre mice with the LCMV strain clone 13, which causes chronic infection 31 . During chronic infection, antigen-specific T cells gradually diminish in their effector functionality and become exhausted cells due to prolonged persistence of antigen in the host 32 . During chronic infection, antigenspecific CD8 + T cells in Atg7 fl/fl Gzmb-Cre mice again mounted an initial response to the virus in the peripheral blood, as well as in lymphoid and nonlymphoid tissues at day 8 after infection, similar to Atg7 fl/fl mice ( Fig. 8a and Supplementary Fig. 7a,b) . Ex vivo stimulation of splenocytes at day 8 after infection showed little difference in the number of cells producing IFN-γ (Fig. 8b) . However, by day 15 after infection, most LCMV-specific T cells were lost in Atg7 fl/fl Gzmb-Cre mice throughout lymphoid and nonlymphoid tissues, similar to results obtained for the acute infection model ( Fig. 8a and Supplementary Fig. 7c,d) . The reduction observed was also reflected in the number of IFN-γ-producing cells after stimulation ex vivo (Fig. 8b) . As a consequence of the loss of most antigenspecific cells, viral control was compromised in Atg7 fl/fl Gzmb-Cre mice (Fig. 8c) . These data further indicated a considerable survival defect in the Atg7-deficient LCMV-specific effector CD8 + T cells: not only were these cells compromised in memory CD8 + T cell differentiation, they also failed to survive in the chronic infection model.
DISCUSSION
Our finding that proliferating T cells underwent decreased autophagy in vivo was unexepected, because published in vitro studies have shown that autophagy is increased in T cells after TCR stimulation 9, 12, 13 . Discrepancies between our study and those published studies might be explained by the vastly different conditions of TCR stimulation in vivo versus in vitro. In addition, in some of those published studies, only a single aspect of the autophagy pathway, such as the number of autophagosomes or the amount of lipidated LC3b-II, was used to assess autophagy activity in cultured T cells. As the autophagy pathway can be blocked at any point along its progression, it has become clear that measuring a single component in the pathway, rather than measuring flux through the pathway (as done here), is not reflective of whether autophagy is activated or blocked 7 . In contrast, the autophagic flux assays used in our experiments meet the current standards; thus, we propose a distinct model of the kinetics of in vivo autophagy activity in antigen-specific CD8 + T cells after viral infection.
Our findings on the kinetics of autophagy in vivo were consistent with our results in which genes encoding molecules essential for autophagy were deleted from antigen-specific CD8 + T cells. The in vivo kinetics of autophagy indicated that activated T cells were able to proliferate with very low autophagy activity; indeed both autophagy-deficient and wild-type virus-specific CD8 + T cell populations were able to expand similarly in most tissues. However, that similar expansion of antigen-specific CD8 + T cell populations in mice with null mutation of autophagy molecule-encoding genes and wild-type mice was unexpected, because a published study has shown that deletion of genes encoding autophagy-related molecules results in compromised T cell proliferation after in vitro stimulation via the TCR 9 . The T cells used in that published study were defective in autophagy for long periods of time before being assayed because the genes encoding autophagy-related molecules were deleted during T cell development 9 . It is known that T cells deficient in the genes encoding autophagy-related molecules are transcriptionally and phenotypically distinct from wild-type T cells 9, 10, 15, 33 . To avoid this complication in our studies, we deleted the genes encoding autophagyrelated molecules specifically from cells expressing granzyme B after T cell activation; therefore, naive T cells were normal at the time of viral infection. Thus, robust expansion of CD8 + T cell populations in the absence of genes encoding autophagy-related molecules would npg suggest that activated T cells can proliferate and differentiate into effector cells without autophagy, which is consistent with the in vivo kinetics of autophagy in antigen-specific CD8 + T cells. In contrast to results obtained for the T cell clonal-expansion phase, autophagy was required for the survival of effector T cells that then formed memory T cells during the contraction phase, when effector T cells undergo substantial changes. In this phase, effector T cells, having just finished many rounds of vigorous cell divisions, potentially accumulate protein aggregates, reactive oxygen species and other superfluous cellular content [34] [35] [36] [37] [38] . Autophagy could serve various prosurvival functions in these cells, including the removal of damaged mitochondria that generate reactive oxygen species or misfolded proteins 39, 40 . Thus, upregulation of autophagy in virusspecific CD8 + T cells upon the conclusion of clonal expansion is important during the contraction phase.
Our results have implications for published studies linking the major regulator of autophagy mTOR to the differentiation of memory CD8 + T cells 27, 41 . Such studies have demonstrated that inhibition of mTOR by rapamycin improves not only the magnitude of memory CD8 + T cells but also their quality 27, 41 . These effects of rapamycin on antigen-specific CD8 + T cells might result from increased autophagy during the expansion and contraction phases. Active mTOR signaling directly downregulated autophagy and therefore inhibition of mTOR would probably enhance autophagy activity 42 . Thus, future studies should investigate whether treatment with rapamycin upregulates autophagy in antigen-specific CD8 + T cells and whether increased autophagy improves the differentiation of memory CD8 + T cells.
Our metabolomics analysis provided insight into regulation of the metabolic pathway by autophagy in virus-specific CD8 + T cells. The unbiased metabolite data revealed that mitochondrial FAO, which has been shown to be critical for the generation of memory T cells 26, 27 , was dysregulated in Atg7-deficient T cells at the peak of clonal expansion, when antigen-specific T cells transition to the memory phase. A study of metabolomic profiles in a mouse cancer model has reported that Atg7-deficient tumor cells have defective mitochondria and diminished FAO 43 . We speculate that T cell-intrinsic autophagy may be important for the generation of lipid substrates for mitochondrial FAO, consistent with published studies showing that autophagy can regulate lipid metabolism via the breakdown of cellular lipid stores 44 . Precisely how the substrates for mitochondrial FAO are used or generated by memory T cells, and whether autophagy directly regulates mitochondrial FAO in antigen-specific effector CD8 + T cells, are subjects for future work.
In addition to showing the importance of autophagy during an acute viral infection, our data demonstrated that autophagy in virus-specific CD8 + T cells was essential for cell survival and for viral control during a chronic infection. It is well established that activated CD8 + T cells during chronic infections or in tumor environments differentiate into exhausted T cells. The 'rejuvenation' of exhausted T cells is a promising approach for treating chronic infections and cancer. Thus, our data suggest critical role for autophagy in the formation and survival of exhausted CD8 + T cells that can be targeted for immunotherapy.
In summary, our data have established that the autophagy pathway is dynamically regulated throughout the CD8 + T cell response and is critical for the formation of T cell memory. Autophagy seems to have a role in the metabolic homeostasis of effector CD8 + T cells during their transition into memory cells. Our studies have implications for the development of effective vaccination strategies and anticancer immunotherapy through targeting of the autophagy pathway and/or other metabolic pathways.
METhODS
Methods and any associated references are available in the online version of the paper.
